Wednesday, June 05, 2019 8:09:18 PM
Request for Trading Halt
In accordance with ASX Listing Rule 17.1, Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ:
BNTCW) (Benitec) requests a trading halt of its securities, effective immediately.
For the purposes of the trading halt, Benitec provides the following information:
(a) Benitec is seeking the trading halt as it expects to make an announcement to the ASX in relation to one of its
existing material contracts;
(b) Benitec requests the trading halt be put in place until the earlier of the commencement of trading on Tuesday 11
June 2019, or when an announcement is released to the market; and
(c) Benitec is not aware of any reason why the trading halt should not be granted or of any other information
necessary to inform the market about the trading halt.
Should you have any queries in relation to this trading halt request, please do not hesitate to contact me.
Yours faithfully
Oliver Kidd
Company Secretary
Recent BNTC News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:37:30 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/14/2024 09:35:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:32:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:31:03 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/13/2024 05:15:09 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/01/2024 09:04:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/23/2024 01:23:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/22/2024 09:24:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 12:07:52 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/15/2024 10:08:11 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/11/2024 09:13:08 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/11/2024 08:53:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 08:52:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 08:45:29 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/01/2024 08:46:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:43:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/26/2024 08:30:45 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/29/2024 08:28:27 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/19/2024 08:59:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 09:18:32 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/29/2024 08:32:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 12:05:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 12:01:01 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM